Fox

Appleton Eagle Scout completes major UWO Fox Cities campus community garden renovation

Though it’s near the end of the growing season, a large community garden on the University of Wisconsin Oshkosh, Fox Cities campus is shining brightly as 15 years of overgrowth was removed and new fencing installed.

Garden beautification efforts―two years in the making―were led by Eagle Scout candidate Elijah Eisen, 17, a junior at Appleton North High School, along with support from Bill Bultman, an emeritus faculty member and Rose Marie Lewis, senior technician on the UWO Fox Cities campus.

Eisen provided much-needed tender loving care to the area and installed new fencing to keep deer and other animals at bay. The garden plots allow individuals and families in the community to grow their own food and flowers. The previous fencing was missing and broken and allowed deer to feast on the garden “like a buffet,” according to gardeners.

With various delays―not the least included the coronavirus pandemic―Eisen is happy the project has finally been completed. He says he was 14 years old when he started planning the garden updates. He had talked to Lewis, unofficial scouting coordinator on campus, about potential Eagle Scout projects.

“Since the beginning, this (Eagle Scout) was my goal,” Eisen said. “I didn’t feel I  accomplished it if I did something small. I wanted one of the biggest projects she had.”

Though Eisen wondered really how hard the project to put up an eight-foot wire fence could be, he soon learned it would take hundreds of volunteer hours digging through layers of clay―and a lot of money.

Pushing through

“I was very up front with him (Eisen) about the scope and complexity of the project, but he has proven to be a very capable and diligent scout,” said Lewis, senior laboratory prep technician at the UWO Fox Cities campus.

Lewis, herself an Eagle Scout mom,

Continue Reading

ImmunoPrecise Antibodies CEO Dr. Jennifer Bath Appeared Live, Sunday October 4th, on Fox & Friends

VICTORIA, BC, Oct. 05, 2020 /CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that Dr. Jennifer Bath, CEO of IPA, was invited Sunday morning, October 4th, as a guest on Fox & Friends with Anchor Jedediah Bila at 7:15a.m. ET.

ImmunoPrecise Antibodies Ltd. Logo (CNW Group/ImmunoPrecise Antibodies Ltd.)

Dr. Bath explained the unique functions of cocktail therapies as they pertain to SARS-CoV-2, including the antibody treatment administered to President Trump.   She also expanded on the importance of the initial design for such strategies and how early steps can be taken to support the safety and efficacy of treatments, but that these tests take time.

IPA launched their Polytope™ Therapy Cocktail, which they believe to be the most promising approach to address a virus like SARS-CoV-2, as it also aims to protect and treat both current and future strains and variants of SARS.

To view Dr. Bath’s interview on Fox & Friends please click here.

About ImmunoPrecise Antibodies Ltd.
ImmunoPrecise is a global technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. The Company’s experience and cutting-edge technologies enable unparalleled support of its partners in their quest to bring innovative treatments to the clinic. ImmunoPrecise’s full-service capabilities dramatically reduce the time required for, and the inherent risk associated with, conventional multi-vendor product development. For further information, visit www.immunoprecise.com or contact [email protected]

Forward Looking Information
This news release contains statements that, to the extent they are not recitations of historical fact, may constitute “forward-looking statements” within the meaning of applicable Canadian securities laws. The Company uses words such as “may”, “would”, “could”, “will”, “likely”, “expect”, “believe”, “intend”, “should” and similar expressions to identify forward-looking statements and include the

Continue Reading

ImmunoPrecise Antibodies CEO Dr. Jennifer Bath Appeared Live, Sunday October 4th, on Fox & Friends | Nachricht

VICTORIA, BC, Oct. 05, 2020 /CNW/ -IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that Dr. Jennifer Bath, CEO of IPA, was invited Sunday morning, October 4th, as a guest on Fox & Friends with Anchor Jedediah Bila at 7:15a.m. ET.

ImmunoPrecise Antibodies Ltd. Logo (CNW Group/ImmunoPrecise Antibodies Ltd.)

Dr. Bath explained the unique functions of cocktail therapies as they pertain to SARS-CoV-2, including the antibody treatment administered to President Trump.   She also expanded on the importance of the initial design for such strategies and how early steps can be taken to support the safety and efficacy of treatments, but that these tests take time.

IPA launched their Polytope™ Therapy Cocktail, which they believe to be the most promising approach to address a virus like SARS-CoV-2, as it also aims to protect and treat both current and future strains and variants of SARS.

To view Dr. Bath’s interview on Fox & Friends please click here.

About ImmunoPrecise Antibodies Ltd.
ImmunoPrecise is a global technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. The Company’s experience and cutting-edge technologies enable unparalleled support of its partners in their quest to bring innovative treatments to the clinic. ImmunoPrecise’s full-service capabilities dramatically reduce the time required for, and the inherent risk associated with, conventional multi-vendor product development. For further information, visit www.immunoprecise.com or contact [email protected]

Forward Looking Information
This news release contains statements that, to the extent they are not recitations of historical fact, may constitute “forward-looking statements” within the meaning of applicable Canadian securities laws. The Company uses words such as “may”, “would”, “could”, “will”, “likely”, “expect”, “believe”, “intend”, “should” and similar expressions to identify forward-looking statements and include the Company’s beliefs

Continue Reading